As 500 partnerships recorded in digital diabetes, there are four types of partnership ecosystems emerged. Building ecosystems is becoming one of the main go-to-market strategies for some digital diabetes solution providers.
Within digital diabetes market landscape, partnership ecosystems have emerged as strategic collaborations among various stakeholders to develop new solutions, offer a holistic care experience, and explore further growth opportunities in the market segment.
Allis recorded 500 partnership deals closed in the digital diabetes market segment since 2014. Total number of partnerships deals signed in 2022 is seven times higher than in 2014. The peak years of the number of digital diabetes collaborations were Y2019 and Y2020, with above 70 partnerships recorded each year.
In H1 2023, digital diabetes market also witnessed more than 20 partnerships, closed with pharmaceuticals, telemedicine providers, health plans, pharmacy benefit managers, among others.
Welldoc has signed a joint partnership with Astellas Pharma and Roche Diabetes Care for development and commercialization of Accu-Chek Guide Me BGM system with Welldoc’s BlueStar platform in Japan.
Diabeloop and Novo Nordisk signed a connected device partnership to enable interoperability between the Diabeloop’s insulin management software and Novo Nordisk smart insulin pens.
DarioHealth closed a strategic partnership with Amwell to deliver its full suite chronic condition management platform to Amwell customers.
Additionally, Vida Health started a partnership with SelectHealth, a health plan in the US, to provide Vida’s cardiometabolic solutions incl. diabetes to its members.
While range of partnerships are being formed, there have been mainly four types of ecosystems emerging in the digital diabetes market.
The number of partnerships is growing in the digital diabetes market. Market players do not stop with one or two partnerships but forming their own ecosystems with range of stakeholders. Their collaborations span across various types of ecosystems, including service expansion, pharma industry, device, and commercial ecosystems. As the market and the competition keep growing, businesses will engage more actively in these ecosystems to seize opportunities for business growth and improved services.